Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurotrophic paths in the treatment of depression.

× No keyword cloud information.

34 in total

1. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.

Authors: Yan-Feng Zou; Dong-Qing Ye; Xiao-Liang Feng; Hong Su; Fa-Ming Pan; Fang-Fang Liao
Journal: Eur Neuropsychopharmacol Date: 2010-02-18 Impact factor: 4.600

Review 2. Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.

Authors: R T Owen
Journal: Drugs Today (Barc) Date: 2012-07 Impact factor: 2.245

Review 3. Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Authors: Kamilla W Miskowiak; Maj Vinberg; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal: Psychopharmacology (Berl) Date: 2011-09-23 Impact factor: 4.530

4. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects.

Authors: Arvind Govindarajan; B S Shankaranarayana Rao; Deepti Nair; Mimi Trinh; Nadya Mawjee; Susumu Tonegawa; Sumantra Chattarji
Journal: Proc Natl Acad Sci U S A Date: 2006-08-21 Impact factor: 11.205

5. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors: Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal: Science Date: 2003-07-18 Impact factor: 47.728

Review 6. VEGF as a potential target for therapeutic intervention in depression.

Authors: Jennifer L Warner-Schmidt; Ronald S Duman
Journal: Curr Opin Pharmacol Date: 2007-12-03 Impact factor: 5.547

7. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice.

Authors: Catharine H Duman; Lee Schlesinger; David S Russell; Ronald S Duman
Journal: Brain Res Date: 2008-01-03 Impact factor: 3.252

8. The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms.

Authors: Warren Caldwell; Opal A McInnis; Robyn J McQuaid; Gele Liu; John D Stead; Hymie Anisman; Shawn Hayley
Journal: PLoS One Date: 2013-06-18 Impact factor: 3.240

9. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met.

Authors: Bernet M Elzinga; Marc L Molendijk; Richard C Oude Voshaar; Boudewijn A A Bus; Jos Prickaerts; Philip Spinhoven; Brenda J W H Penninx
Journal: Psychopharmacology (Berl) Date: 2010-08-12 Impact factor: 4.530

Review 10. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.

Authors: Ronald S Duman
Journal: Dialogues Clin Neurosci Date: 2009 Impact factor: 5.986

2 in total

1. Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults.

Authors: Kerri S Rawson; David Dixon; Petra Nowotny; William M Ricci; Ellen F Binder; Thomas L Rodebaugh; Leah Wendleton; Peter Doré; Eric J Lenze
Journal: PLoS One Date: 2015-03-17 Impact factor: 3.240

Review 2. Cytokine variations and mood disorders: influence of social stressors and social support.

Authors: Marie-Claude Audet; Robyn J McQuaid; Zul Merali; Hymie Anisman
Journal: Front Neurosci Date: 2014-12-16 Impact factor: 4.677

2 in total